Here, we utilize two well‐characterized genetic ALS zebrafish models expressing mutant forms of SOD1 and TARDBP to identify a new neuroprotective role for Cipro/Celecox drug combination, suggesting that it may serve as an effective treatment in ALS. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.